ROZA KARABANOV: Open Payments
NPI 1457842502 · LITTLE FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 25 payments from 8 companies in 2025. Trend: 2023 $247 · 2024 $669 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| ABBVIE INC. | 4 | $75 |
| SHIELD THERAPEUTICS INC | 3 | $66 |
| PFIZER INC. | 3 | $63 |
| Amgen Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: ACCRUFER, PREVNAR 20, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, QULIPTA, UBRELVY, SHINGRIX.
Industry payments across NY — which companies pay providers there.
